A new treatment for panic disorder
- Conditions
- Panic disorderTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- Registration Number
- EUCTR2015-005338-23-NL
- Lead Sponsor
- niversity of Amsterdam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
- Aged between 18 and 65 years
- A primary diagnosis of panic disorder according to DSM-V
- Written approval of an independent physician for participation
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
- Other relevant treatment for panic disorder at the time of study - e.g., CBT
- Diagnosis of depression
- Diagnosis of psychosis
- Use of psychotropic medication
- History of pulmonary diseases
- Metabolic acidosis
- History of cardiovascular diseases
- Heart problems among first-degree relatives
- HR<60
- BP < 90-60 or BP > 170-100
- History of black-outs or fainting
- Diabetes
- Liver or kidney diseases
- Hyperactive production of thyroid hormones
- Epilepsy
- Any medication contra-indicative of the use of propranolol
- Pregnancy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method